PFLPhysiological Fitness Landscape

Biomarkers · Coagulation

Plasminogen Activator Inhibitor-1 (PAI-1)

No risk curve catalogued yet.

What studies found when this marker was changed

They describe what happened in those study groups, not a recommendation. See all catalogued interventions.

Measured changes in PAI-1, study by study

4 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Study results in the groups studied, not predictions for a person.

Each row is one study: what was changed, the effect it reported on this marker, and the source.
TypeInterventionReported effectEvidenceSource
dietAd libitum diet enriched with Iberian cured ham (acorn- or mixed-fed) for 6 weeks in healthy adults aged 25-55PAI-1 change -6.2 +/- 17.7 ng/mL with cured ham vs +0.3 +/- 1.4 ng/mL control after 6 weeks (P=0.020), persisting 6 weeks after stoppingRCTSaban-Ruiz J, et al. The journal of nutrition, health & aging. 2017. Iberian…
pharmacologicStatin therapy of any type and dose vs control (16 RCTs, 19 treatment arms)Lowers plasma PAI-1 concentration by 15.72 ng/mL (95% CI -25.01 to -6.43)meta-analysisSahebkar A, et al. Thrombosis and haemostasis. 2016. Impact of statin therapy…
pharmacologicFibrate therapy (gemfibrozil 6 trials, bezafibrate 4, fenofibrate 5) vs controlNo significant change in plasma PAI-1 concentration: -11.39 ng/mL (95% CI -26.64 to 3.85)meta-analysisSahebkar A, et al. Atherosclerosis. 2015. Impact of fibrate therapy on plasma…

What else moves this marker

They describe those study groups, not an individual, and an association is not a cause.

Diseases and conditions

Each row is one study: what it compared and the change it reported in this marker.
WhatEffect on the markerComparison · populationSource
↑ Major depressive disorder · patients with MDD vs healthy controlsSMD +0.27 (95% CI 0.01 to 0.53)MDD patients vs healthy controls · 507 patients with major depressive disorder and 3453 controls (6 studies)meta analysis · PMID 34798692
↑ Non-alcoholic fatty liver disease · patients with NAFLD vs controls+17.15 ng/mL (95% CI 7.72 to 26.57)NAFLD patients vs non-NAFLD controls · Adults with NAFLD (imaging- or biopsy-diagnosed) and controls (11 of 33 studies pooled)meta analysis · PMID 35574617

Sources

  • See the catalogue entry in the research dashboard.

Related markers: Angiopoietin-2 · Coagulation Factor VIII · Coagulation Factor VIIc · D-dimer · Plasma Viscosity · Soluble ICAM-1 (sICAM-1) · von Willebrand Factor (vWF)